Hepatitis B, Chronic - 28 Studies Found

Active, not recruiting : Tenofovir Disoproxil Fumarate (TDF) 300mg 3 Years RD Therapy Chinese Chronic Hepatitis B (CHN) CHB Multiple Nucleos(t)Ide Analogues (NAs) Failure Points Pts PH4 PMS Study
: Hepatitis B, Chronic
: 2014-07-17
: Drug: Tenofovir disoproxil fumarate Tenofovir disoproxil fumarate tablets supplied will be white, almond
Completed : A Single-arm Study Evaluating the Efficacy and Safety of Telbivudine With or Without add-on Tenofovir in Adults With HBeAg-positive Chronic Hepatitis B (CHB)
: Hepatitis B, Chronic
: 2008-03-18
: Drug: Tenofovir All patients receive 600 mg/day, oral telbivudine for 24 weeks. Patients with non-detect
Completed : Entecavir Plus Adefovir in Lamivudine-Resistant Chronic Hepatitis B Patients Who Fail Lamivudine Plus Adefovir
: Hepatitis B, Chronic
: 2009-12-01
:
  • Drug: Adefovir Adefovir dipivo
Completed : KRN7000 in Chronic Hepatitis B
: Hepatitis B, Chronic
: 2006-08-10
: Drug: KRN7000
Completed : Long-Term Lamivudine Therapy for Chronic Hepatitis B
: Hepatitis B, Chronic
: 2005-07-15
:
  • Procedure: Blood Testing
  • Procedure: Percut
Active, not recruiting : Efficacy and Safety Study of Tenofovir Disoproxil Fumarate (TDF) in Chinese Chronic Hepatitis B (CHB) Subjects With Advanced Fibrosis & Compensated Cirrhosis
: Hepatitis B, Chronic
: 2014-08-21
: Drug: Tenofovir disoproxil fumarate White, almond-shaped, film-coated tablet containing 300 mg of TDF, d
Completed : Study of Adefovir Dipivoxil for Korean Patients With Chronic Hepatitis B(CHB) Who Have Completed ADF 103814
:
  • Hepatitis B, Chronic
  • Chronic Hepatitis B<
    : 2006-11-23
    : Drug: adefovir dipivoxil 10mg
Completed : PegIntron Treatment of Chronic Hepatitis B e Antigen-Positive Patients (P05170/MK-4031-327)
: Hepatitis B, Chronic
: 2007-09-26
:
  • Drug: pegylated interferon alpha-2b

Enrolling by invitation : Use of TDF in Patients With Inactive Chronic Hepatitis B Infection
: Hepatitis B, Chronic
: 2015-11-03
: Drug: Tenofovir disoproxil fumarate 300 mg, oral, once a day
Completed : A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Patients With Chronic Hepatitis B.
: Hepatitis B, Chronic
: 2007-06-18
: Drug: peginterferon alfa-2a [Pegasys] 180 micrograms sc weekly for 48 weeks
<<< Previous | Next >>>